1. Home
  2. GRABW vs CMMB Comparison

GRABW vs CMMB Comparison

Compare GRABW & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRABW
  • CMMB
  • Stock Information
  • Founded
  • GRABW N/A
  • CMMB 2004
  • Country
  • GRABW Singapore
  • CMMB Israel
  • Employees
  • GRABW 10604
  • CMMB N/A
  • Industry
  • GRABW Business Services
  • CMMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRABW Consumer Discretionary
  • CMMB Health Care
  • Exchange
  • GRABW Nasdaq
  • CMMB Nasdaq
  • Market Cap
  • GRABW N/A
  • CMMB 37.3M
  • IPO Year
  • GRABW N/A
  • CMMB N/A
  • Fundamental
  • Price
  • GRABW $0.46
  • CMMB $1.97
  • Analyst Decision
  • GRABW
  • CMMB Strong Buy
  • Analyst Count
  • GRABW 0
  • CMMB 2
  • Target Price
  • GRABW N/A
  • CMMB $7.50
  • AVG Volume (30 Days)
  • GRABW N/A
  • CMMB 82.4K
  • Earning Date
  • GRABW N/A
  • CMMB 03-06-2025
  • Dividend Yield
  • GRABW N/A
  • CMMB N/A
  • EPS Growth
  • GRABW N/A
  • CMMB N/A
  • EPS
  • GRABW N/A
  • CMMB N/A
  • Revenue
  • GRABW N/A
  • CMMB N/A
  • Revenue This Year
  • GRABW N/A
  • CMMB N/A
  • Revenue Next Year
  • GRABW N/A
  • CMMB N/A
  • P/E Ratio
  • GRABW N/A
  • CMMB N/A
  • Revenue Growth
  • GRABW N/A
  • CMMB N/A
  • 52 Week Low
  • GRABW N/A
  • CMMB $0.55
  • 52 Week High
  • GRABW N/A
  • CMMB $2.55
  • Technical
  • Relative Strength Index (RSI)
  • GRABW 49.92
  • CMMB 56.98
  • Support Level
  • GRABW $0.44
  • CMMB $2.02
  • Resistance Level
  • GRABW $0.55
  • CMMB $2.15
  • Average True Range (ATR)
  • GRABW 0.05
  • CMMB 0.12
  • MACD
  • GRABW 0.01
  • CMMB -0.01
  • Stochastic Oscillator
  • GRABW 37.85
  • CMMB 69.57

About GRABW Grab Holdings Limited Warrant

Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Share on Social Networks: